New Edge Advisors, LLC Aspira Women'S Health Inc. Transaction History

New Edge Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$0.88 - $1.81 $8,800 - $18,100	10,000 New	10,000 $10,000
Q4 2021 Feb 17, 2022	SELL	$1.63 - $3.43 $16,299 - $34,300	-10,000 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$4.78 - $6.84 $47,800 - $68,400	10,000 New	10,000 $56,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.